# Ulhas M. Nadgir, M.D. – FDA Inspection, Oct 10, 2024

Source: https://www.keypedia.com/records/fda_inspections/ulhas-m-nadgir-md/d684c021-e768-488f-8840-70d3fa4346a9
Source feed: FDA_Inspections

> FDA inspection 1251475 of Ulhas M. Nadgir, M.D., October 10, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251475
- Company Name: Ulhas M. Nadgir, M.D.
- Inspection Date: 2024-10-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/stephanie-barragan/fc1bc901-1467-4fdd-bee3-f87f2db3a1fa)

Company: https://www.keypedia.com/companies/ulhas-m-nadgir-md/f7c33197-3df2-4285-a7c2-846d46e2741e

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
